• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Aldeyra Therapeutics, Inc. (ALDX)

    -NasdaqCM
    6.74 Down 0.31(4.40%) 3:59PM EST
    Add to Portfolio
    Prev Close:7.05
    Open:7.27
    Bid:5.14 x 100
    Ask:8.88 x 500
    1y Target Est:21.33
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:6.72 - 7.73
    52wk Range:3.00 - 11.99
    Volume:8,020
    Avg Vol (3m):16,388
    Market Cap:42.09M
    P/E (ttm):N/A
    EPS (ttm):-2.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALDX

    Comparison

    Symbol% ChgMkt Cap
    ALDXDown 4.40%42.09M
    ABBVUp 2.02%106.06B
    JNJUp 1.27%291.30B
    NVSUp 0.70%223.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.01
    Quarterly EPS Est (Dec-14) :-0.40
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aldeyra Therapeutics, Inc. develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases, and slow the progression of chronic disease. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback